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Abstract
In this paper, we studied phase-space analysis of a certain mathematical
model of tumor growth with an immune responses and chemotherapy therapy.
Mathematical modelling of this process is viewed as a potentially powerful tool
in the development of improved treatment regimens. Mathematical analysis
of the model equations with multipoint initial condition, regarding nature of
equilibria, local and global stability have been investigated. We studied some
features of behavior of one of three-dimensional tumor growth models with
dynamics described in terms of densities of three cells populations: tumor cells,
healthy host cells and effector immune cells. We found sufficient conditions,
under which trajectories from the positive domain of feasible multipoint initial
conditions tend to one of equilibrium points. The addition of a drug term to the
system can move the solution trajectory into a desirable basin of attraction. We
show that the solutions of the model with a time-varying drug term approach
can be evaluated more fruitful way and down to earth style from the point of
practical importance than the solutions of the system without drug treatment,
in the condition of stimulated immune processes, only.
Keywords: Mathematical modeling of timor dinamics, Immune system,
Stability of dynamical systems, Drug treatment, Multiphase attractors
1. Introduction
Beginning with this article, we intend to attempt to investigate the problems
of mathematical and biological approaches to the modeling of cancer growth dy-
namics processes and operations, enlisting a new parameter as chemotherapeutic
agent to the system, consisted of host, tumor and immune cells. The mathemat-
ical processing of the model is based on nonlinear property of cancer growth,
when it concerns the foundation of the model’s logistic part. This approach
appears very convenient in description of unexpected dynamics in the processes
of growth in response to changing reactions of the system to different concen-
trations of immune cells and drug application at the different stages of cancer
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growth development [1− 13]. Taking into account all the complex processes,
nonlinear mathematical models can be estimated capable of compensation and
minimization the inconsistencies between different mathematical models related
to cancer growth-anticancer factor affections. The elaboration of mathematical
non-spatial models of the cancer tumor growth in the broad framework of tu-
mor immune interactions studies is one of intensively developing areas in the
modern mathematical biology, see works [1− 7]. Of course, for the development
of a powerful mathematical model on cancer immunotherapy, it is required first
of all, an understanding of the mechanisms governing the dynamics of tumor
growth. One of the main reasons for creation of non-spatial dynamical models of
a multiphase nature is related to the fact that they are described by a system of
ordinary differential equations, which can be efficiently investigated by powerful
methods of qualitative theory of ordinary differential equations and dynamical
systems theory. In this paper, we examine the dynamics of a cancer growth
model with drug interaction proposed in [5], taking account the system as a
multiphase structure, i.e. in dynamics:
T˙ = r1T
(
1− k−11 T
)
− a12NT − a13TI − g1 (u)T,
N˙ = r2N
(
1− k−12 N
)
− a21NT − g2 (u)N, (1.1)
I˙ = s+
r3IT
k3 + T
− a31IT − d3I − g3 (u) I,
u˙+ d2u (t) = υ (t)
with multipoint initial condition
T (t0) = T0 +
m∑
j=1
α1jT (tj) , N (t0) = N0 +
m∑
j=1
α2jN (tj) , (1.2)
I (t0) = I0 +
m∑
j=1
α3jI (tj) , t0 ∈ [0, δ) , tj ∈ (0, δ) , tj > t0, u (t0) = u0,
where T = T (t) , N = N (t), I = I (t) denote the densities of tumor cells,
healthy host cells and the effector immune cells respectively, at the moment t,
ki > 0, αij are real numbers, m is a natural number such that
T (t0) > 0, N (t0) > 0, I (t0) > 0
and
gi (u) ≥ 0, gi (0) = 0, lim
u→∞
gi (u) = ai > 0, i = 1, 2, 3. (1.3)
For
gi (u) = ai
(
1− e−νiu
)
, νi > 0, i = 1, 2, 3 (1.4)
we generalize the case that has been derived in [5] .
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The source of the immune cells is considered to be outside of the system so it
is reasonable to assume a constant influx rate s, furthermore, in the absence of
any tumor, the cells will die off at a per capita rate d3, resulting in a long-term
population size of s/d3 cells, u(t) denotes the amount of drug at the tumor site
at time t, this is determined by the dose given υ(t), and a per capita decay rate
of the drug once it is injected, here it is assumed that the drug kills all types of
cells, but that the kill rate differs for each type of cell, with the response curve
in all cases given by
g(u) = (g1(u), g2(u), g3(u)) .
For case of (1.4), g(u) is the fractional cell kill for a given amount of drug u, at
the tumor site, this decay rate incorporates all pathways of elimination of the
drug, by a1, a2 and a3 denoted the three different response coefficients, here
a = (a1, a2, a3) , ν = (ν1, ν2, ν3) .
The first term of the first equation corresponds to the logistic growth of tumor
cells, in the absence of any effect from other cells populations, with the growth
rate of r1 and maximum carrying capacity k1. The competition between host
cells and tumor cells T (t) which results in the loss of the tumor cells population
is given by the term a12NT . Next, the parameter a13 refers to the tumor cell
killing rate by the immune cells I (t). In the second equation, the healthy tissue
cells also grow logistically with the growth rate of r2 and maximum carrying
capacity k2. We assume that the cancer cells proliferate faster than the healthy
cells which gives r1 > r2. The tumor cells also inactivate the healthy cells at the
rate of a21. The third equation of the model describes the change in the immune
cells population with time t. The first term of the third equation illustrates
the stimulation of the immune system by the tumor cells with tumor specific
antigens. The rate of recognition of the tumor cells by the immune system
depends on the antigenicity of the tumor cells. The model of the recognition
process is given by the rational function which depends on the number of tumor
cells with positive constants r3 and k3. The immune cells are inactivated by
the tumor cells at the rate of a31 as well as they die naturally at the rate d3,
here we suppose that the constant influx of the activated effector cells into the
tumor microenvironment is zero. We suppose that the constant influx s of the
activated effector cells into the tumour microenvironment is zero.
Therein, note that, the nonlinear dynamic systems and references studied
e.g. in [14 − 15]. One of main aims is derivation of sufficient conditions under
which the possible biologically feasible dynamics is local and globally stable,
and converges to one of equilibrium points. Since these equilibrium points have
a biological sense, we notice that understanding limit properties of dynamics of
cells populations based on solving problems (1.1)− (1.2) may be of an essential
interest for the prediction of health conditions of a patient without a treatment,
when the data (e.g. the status of blood cells shown above) that determines
the condition of the patient are compared at various times t0, t1, ..., tm and
correlated. Note that the local and global stability properties of (1.1) with the
classical initial condition were studied in [8] and [9], respectively. We prove that
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all orbits are bounded and must converge to one of several possible equilibrium
points. Therefore, the long-term behavior of an orbit is classified according to
the basin of multipoint attraction in which it starts. By scaling x1 = Tk
−1
1 ,
x2 = Nk
−1
2 , x3 = Ik
−1
3 , t˜ = r1t in (1.1)− (1.2) and omitting the tilde notation
we obtain the multipoint initial value problem (IVP)
x˙1 = x1 (1− x1)− a12x1x2 − a13x1x3 − g1 (u)x1,
x˙2 = r2x2 (1− x2)− a21x1x2 − g2 (u)x2, (1.5)
x˙3 =
r3x1x3
x1 + k3
− a31x1x3 − d3x3 − g3 (u)x3, t ∈ [0, T ) ,
u˙+ d2u (t) = υ (t) , u (t0) = u0,
x1 (t0) = x10 +
m∑
j=1
α1jx1 (tj) , x2 (t0) = x20 +
m∑
j=1
α2jx2 (tj) , (1.6)
x3 (t0) = x30 +
m∑
j=1
α3jx3 (tj) , t0 ∈ [0, δ) , tj ∈ (0, T ) , tj > t0,
where αij are real numbers and m is a natural number such that
xj0 +
m∑
k=1
αjkxj (tk) ≥ 0, j = 1, 2, 3. (1.7)
By solving the problem
u˙ (t) + d2u (t) = υ (t) , u (t0) = u0 (1.8)
we get
u (t) = et0u0 +
t∫
t0
e−(t−τ)υ (τ) dτ, t ∈ (0, T ] , (1.9)
i.e. the sustem (1.5) is equivalent to the following
x˙1 = x1 (1− x1)− a12x1x2 − a13x1x3 − g1 (υ)x1,
x˙2 = r2x2 (1− x2)− a21x1x2 − g2 (υ)x2, (1.10)
x˙3 =
r3x1x3
x1 + k3
− a31x1x3 − d3x3 − g3 (υ)x3, t ∈ [0, T ) ,
where gi (υ) = fi (u) , here u is defined by (1.9) . Note that, for αj1 = αj2 =
...αjm = 0 the problem (1.5)− (1.6) turns to be the Cauchy problem
x˙1 = x1 (1− x1)− a12x1x2 − a13x1x3 − g1 (u)x1,
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x˙2 = r2x2 (1− x2)− a21x1x2 − g2 (u)x2, (1.11)
x˙3 =
r3x1x3
x1 + k3
− a31x1x3 − d3x3 − g3 (u)x3,
u˙+ d2u (t) = υ (t) , t ∈ [0, T ] ,
x1 (t0) = x10, x2 (t0) = x20, x3 (t0) = x30, u (t0) = u0, t0 ∈ [0, T ) .
2. Notations and background.
Consider the multipoint IVP for nonlinear equation
du
dt
= f (u) , t ∈ [0, T ] , (2.1)
u (t0) = u0 +
m∑
k=1
αku (tk) , t0 ∈ [0, T ) , tk ∈ (0, T ) , tk > t0
in a Banach space X , where αk are complex numbers, m is a natural number
and u = u (t) is a X−valued function. Note that, for α1 = α2 = ...αm = 0 the
problem (2.1) becomes the following local Cauchy problem
du
dt
= f (u) , u (t0) = u0, t ∈ [0, T ] , t0 ∈ [0, T ) . (2.2)
For u0 ∈ X let B¯r (u0) denotes a closed ball in X with radius r centered at
u0, i.e.,
B¯r (u0) = {u ∈ X : ‖u− u0‖X ≤ r} .
From [19] we have
Theorem 2.1. Let X be a Banach space. Suppose f : X → X satisfies
local Lipschitz condition on B¯r(υ0) ⊂ X , i.e.
‖f (u)− f (υ)‖X ≤ L ‖u− υ‖X
for each u, υ ∈ B¯r(υ0) and there exists δ > 0 such that
tk ∈ Oδ (t0) = {t ∈ R : |t− t0| < δ} ,
where
υ0 = u0 +
m∑
k=1
αku (tk) .
Moreover, let
M = sup
u∈B¯r(υ0)
‖f (u)‖X <∞.
Then, problem (2.1) has a unique continuously differentiable local solution
u(t), for t ∈ Oδ (t0), where δ ≤
r
M
.
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Theorem 2.2. Let X be a Banach space. Suppose that f : X → X satisfies
global Lipschitz condition, i.e.
‖f (u)− f (υ)‖X ≤ L ‖u− υ‖X
for each u, υ ∈ X . Moreover, let
M = sup
u∈X
‖f (u)‖X <∞.
Then problem (2.1) has a unique continuously differentiable local solution
u(t), for |t− t0| < δ, where δ ≤
r
M
.
Let X be a Banach space. w ∈ X is called a critical point (or equilibria
point) for the equation (2.1) if f (w) = 0.
We denote the solution of the problem (2.1) by
φ (t, u0) = φ (t, u (t0) , u (t1) , ..., u (tm)) .
Definition 2.1. Let u0 ∈ X . A critical point w ∈ X of the equation (2.1)
is called a positive multiphase attractor if there exists a neighbourhood Ow ⊂ X
of w such that the relation
u0 = u (t0)−
m∑
k=1
αku (tk) ⊂ Ow for t0 ∈ [0, T ) , tk ∈ (0, T ) , tk > t0
implies lim
t→∞
u (t) = w.
Definition 2.2. Assume w ∈ X is a multiphase attractor of (2.1) . A set of
u0 ∈ X with a property that for solution φ (t, u0) of (2.1) we have lim
t→∞
u (t) = w,
is called a domain of multiphase attractor (domain of multiphase asymptotic
stability, or multiphase basin) of w.
3. The equilibria points, existence and local stability
The equilibria points of the system (1.3) are obtained by solving the system
of isocline equations
x1 (1− x1)− a12x1x2 − a13x1x3 − g1 (υ) x1 = 0,
r2x2 (1− x2)− a21x1x2 − g2 (υ)x2 = 0, (3.1)
r3x1x3
x1 + k3
− a31x1x3 − d3x3 − g3 (υ)x3 = 0.
Since we are interested in biologically relevant solutions of (3.1) , we find suffi-
cient conditions under which this system have positive solutions.
It is clear to see that the points E0 (0, 0, 0), E1 (γ, 0, 0), E2 (0, δ, 0) are equi-
libria points for the system of (1.11), where
γ = 1− g1 (υ) , δ = 1−
g2 (υ)
r2
. (3.2)
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Remark 3.1. It is clear that the points E0 (0, 0, 0), E1 (γ, 0, 0), E2 (0, δ, 0)
are biologically feasible equilibria points for the system (1.10).
Let
R3+ =
{
x ∈ R3: xi > 0, i = 1, 2, 3
}
.
Remark 3.2. (1) consider the equilibrium points E0 (0, 0, 0) ; for E0 three
type cell populations are zero; (2) for points E1 (γ, 0, 0) tumor cells have survived
but normal and immune cells are zero, this case can be called as ”dead” case;
(3) E2 (0, δ, 0)-tumor-free and immune free case; in this category, normal cells
have survived but tumor and immune cells are zero.
We now, will derive that the linearized matrices of the system (1.11) for
equilibria points E0 (0, 0, 0), E1 (γ, 0, 0) , E2 (0, δ, 0) are following:
A0 =

 γ 0 00 d22 0
0 0 c33

 , A1 =

 d11 −a12γ −a13γ0 d22 0
0 0 d33

 , A2 =

 c11 0 0−a21δ c22 0
0 0 c33

 ,
(3.3)
where
d11 = 1− 2γ − g1 (υ) , d22 = r2 − a21γ − g2 (υ) ,
d33 =
(
r3
γ + k3
− a31
)
γ − d3 − g3 (υ) , c11 = 1− a12δ − g1 (υ) , (3.4)
c22 = r2 (1− 2δ)− a21δ − g2 (υ) , c33 = −d3 − g3 (υ) .
4. local stability analysis of equilibria points
In this section we show the following result:
Theorem 4.1. (1) E0 (0, 0, 0) is a locally asymptotically stable point if
g1 (υ) > 1, g2 (υ) > r2 and E0 is an unstable point if g1 (υ) < 1, g2 (υ) < r2;
(2) E1 (γ, 0, 0) is a locally asymptotically stable point for the linearized system
of (1.11) when dii < 0 for i = 1, 2, 3, it is an unstable point when dii > 0;
(3) E2 (0, δ, 0) is a locally asymptotically stable point for linearized system of
(1.11) when cii < 0 for i = 1, 2, it is an unstable point if cii > 0, where γ, δ
were defined by (3.2) and dii, cii, i = 1, 2, 3 defined by (3.4) .
Proof. Indeed, the eigenvalues of the matrix A0 are γ, d22, c33; eigenvalues
of the matrix A1 are dii and eigenvalues of the matrix A2 are cii. Hence, by
[5, Theorem 8.12] we obtain the assertions.
Theorem 4.2. Let g1 (υ) > 1 and g2 (υ) > r2. Then, the dimension of the
stable manifold W+0 and unstable manifold W
−−
0 are given, respectively, by
Dim W+0 (E0 (0, 0, 0)) = 1, Dim
(
W−−0 E0 (0, 0, 0)
)
= 1. (4.1)
Proof. Let we solve the the following matrix equation
A0x = λx, (4.2)
7
i.e. consider the system of homogenous linear equation
(1− g1 (υ)− λ)x1 = 0, (r2 − g2υ − λ)x2 = 0, − (d3 + g3 (υ) + λ)x3 = 0.
By solving of (4.2) we get that eigenspaces corresponding to eigenvalues λ1 = γ,
λ2 = d22, λ3 = θ are respectively, the follwing:
B01 =
{
x ∈ R3 : x = (a, 0, 0)
}
,
B02 =
{
x ∈ R3 : x = (0, a, 0)
}
, B03 =
{
x ∈ R3 : x = (a, b, 0)
}
where a is any real number, i.e. we obtain (4.1) .
In a similar way we obtain
Theorem 4.3. Let g1 (υ) < 1 and g2 (υ) < r2. Then, the dimension of the
hyperbolic saddle manifold W 0 is given by
Dim W 0 (E0 (0, 0, 0)) = 1.
Theorem 4.4. Let dii < 0, i = 1, 2, 3. Then, the dimension of the stable
manifold W+1 and unstable manifold W
−−
1 are given, respectively, by
Dim W+0 (E1 (γ, 0, 0)) = 1, Dim W
−−
0 (E0 (γ, 0, 0)) = 1. (4.3)
Proof. Let we solve the the following matrix equation
A1x = λx, (4.4)
i.e. consider the system of homogenous linear equation
(d11 − λ)x1 − a12γx2 = 0, (d22 − λ)x2 = 0, (d33 − λ)x3 = 0.
By solving of (4.4) we get that eigenspaces corresponding to eigenvalues λ1 =
d11, λ2 = d22, λ3 = d33 are respectively, the follwing:
B11 =
{
x ∈ R3 : x = (a, 0, 0)
}
,
B12 =
{
x ∈ R3 : x = (b, a, 0)
}
, B13 =
{
x ∈ R3 : x = (0, 0, a)
}
,
where a is any real number and
b =
(1− 2γ − r2 + g2 (υ))
a12γ
,
i.e. we obtain (4.3) .
In a similar way we obtain
Theorem 4.5. Let dii > 0. Then, the dimension of the hyperbolic saddle
manifold W 01 is given by
Dim W 01 (E1 (γ, 0, 0)) = 1.
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Theorem 4.6. Let cii < 0, i = 1, 2, 3. Then, the dimension of the stable
manifold W+2 and unstable manifold W
−−
2 are given, respectively, by
Dim W+2 (E1 (0, δ, 0)) = 1, Dim W
−−
0 (E2 (0, δ, 0)) = 1. (4.5)
Proof. Let we solve the the following matrix equation
A2x = λx, (4.6)
i.e. consider the system of homogenous linear equation
(c11 − λ)x1 = 0, − a21δx1 + (c22 − λ)x2 = 0, (c33 − λ) x3 = 0,
where cii were defined by (3.4) . By solving of (4.6) we get that eigenspaces
corresponding to eigenvalues λ1 = c11, λ2 = c22, λ3 = c33 are respectively, the
follwing:
B21 =
{
x ∈ R3 : x = (a, 0, 0)
}
,
B22 =
{
x ∈ R3 : x = (0, a, 0)
}
, B23 =
{
x ∈ R3 : x = (0, 0, a)
}
,
where a is any real number. i.e. we obtain (4.5) .
In a similar way we obtain
Theorem 4.7. Let cii > 0. Then, the dimension of the hyperbolic saddle
manifold W 02 is given by
Dim W 02 (E2 (0, δ, 0)) = 1.
Definition 4.1. A set A ⊂ S is called a strong multipoint attractor with
respect to S if
lim sup
t→∞
ρ (u (t) , A) = 0,
where u (t) is an orbit such that u (t0)−
m∑
k=1
αku (tk) ∈ S and ρ is the Euclidean
distance function.
Lemma 5.1. B is a strong multipoint attractor with respect to R3+.
Proof. The proof is done using standard comparison as in Theorem 3.1.
5. Global stability of equilibria points
In this section, we will derive global stability condition of equilibria points
E0 (0, 0, 0), E1 (γ, 0, 0), E2 (0, δ, 0) .
Let
R3+ = {x = (x1, x2, x3) ∈ R
n, xk ≥ 0} , ΩK =
{
x ∈ R3: 0 ≤ xi ≤ Ki, i = 1, 2, 3
}
and
Br (x¯) =
{
x ∈ R3, ‖x− x¯‖R3 < r
2
}
.
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Theorem 5.0. Assume: (1) g1 (υ) > 1 and g2 (υ) > r2;(2) a31k3 > r3. Then
the system (1.11) is global asymptotically stabile at equilibria point E0 (0, 0, 0) .
Proof. Let A0 be the linearized matrix with respect to equilibria point
E0 (0, 0, 0) , i.e.
A0 =

 1− g1 (υ) 0 00 r2 − g2 (υ) 0
0 0 −d3 − g3 (υ)

 .
We consider the Lyapunov equation
B0A0 +A
T
0 B0 = −I, B0 =

 b11 b12 b13b21 b22 b23
b31 b32 b33

 .
The equation above is reduced to linear system of algebraic equation with re-
spect to bij . By solving this algebraic equation we get
b11 =
1
2 (g1 (υ)− 1)
, b22 =
1
2 (g2 (υ)− r2)
, b33 =
1
2 (g3 (υ) + d3)
,
bij = 0, i 6= j, i, j = 1, 2, 3,
i.e.,
B0 =

 b11 0 00 b22 0
0 0 b33

 .
Hence,
P0 (λ) = |B0 − λI| = (b11 − λ) (b22 − λ) (b33 − λ) = 0. (5.0)
By assumtion, eigenvalues λ1 = b11, λ2 = b22, λ3 = b33 of the matrix B0 are
positive. So, the quadratic function
V0 (x) = X
TB0X = b11x
2
1 + b22x
2
2 + b33x
2
3 (5.v0)
is a positive defined Lyapunov function candidate in the certain neighborhood
of E0 (0, 0, 0) . By [12, Corollary 8.2] we need now to determine a domain Ω0
about the point E1, where V˙0 (x) is negatively defined and a constant C such
that ΩC is a subset of Ω0. By assuming xk ≥ 0, k = 1, 2, 3, we will find the
solution set of the following inequality
V˙0 (x) =
3∑
k=1
∂V0
∂xk
dxk
dt
= 2b11 (1− g1 (υ))x
2
1 + 2b22 (r2 − g2 (υ))x
2
2−
2b33 (d3 + g3 (υ))x
2
3 − 2b11x
3
1 − 2b22x
3
2 − 2b11g1 (υ) x
2
1−
10
2b11x
2
1 (a12x2 + a13x3)− 2b22g2 (υ)x
2
2−
2b22a21x
2
2x1 + 2b33x
2
3
[
r3x1
x1 + k3
− a31x1
]
< 0 (5.1)
For x ∈ R3+ we have
−2b11x
3
1 − 2b22x
3
2 − 2b11x
2
1 (a12x2 + a13x3)−−2b22a21x
2
2x1 ≤ 0.
Hence, in view of inequalities
2ab ≤ a2 + b2, x21 + x
2
2 ≤ ‖x‖
2
, x22 + x
2
3 ≤ ‖x‖
2
(5.2)
for x ∈ R3+ we obtain that the inequality (5.1) holds if
2b11 (1− g1 (υ))x
2
1 + 2b22 (r2 − g2 (υ))x
2
2 − 2b33 (d3 + g3 (υ))x
2
3 ≤ 0,
r3
x1 + k3
− a31 < 0. (5.3)
By assumption (1) the first inequality of (5.3) are satisfied for all x ∈ R3
and the second ınequlity holds by assumption (2). So, V˙0 (x) < 0 for x ∈ R
3
+,
i.e. the point E0 is global asymptotically stabile at equilibria point.
Theorem 5.1. Assume: (1) d11 < 0, d22 < 0, d33 < 0; (2); − (d22 + d33) <
a21γ,
γ < −2 (d11 + d22) , − 2d22a
2
12γ < a21
[
a212γ + d11 (d11 + d22)
]
,
(3)
b22
2
≥
2b212
b11
,
b33
2
≥
2b213
b11
,
b33
2
≥
2b223
b22
;
(4)
r2 > g2 (υ) , (a12 + γd22) a12γ < d11 (d11 + d12) .
Then the system (1.10) is global asymptotically stabile at equilibria point
E1 (γ, 0, 0) .
Proof. Let A1 be the linearized matrix with respect to equilibria point
E1 (γ, 0, 0) , i.e.
A1 =

 d11 −a12γ −a13γ0 d22 0
0 0 d33

 ,
where d11 was defined by (3.4) .
By assumption (1), dii < 0. We consider the Lyapunov equation
B1A1 +A
T
1 B1 = −I, (5.4)
where
B1 =

 b11 b12 b13b21 b22 b23
b31 b32 b33

 .
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The equation (5.4) is reduced the linear system of algebraic equation with re-
spect to bij , by solving which we obtain
b11 = −
1
2d11
, b12 = b21 = −
a12γ
2d11 (d11 + d22)
, b13 = b31 =
−
a13γ
2d11 (d11 + d22)
, b22 =
1
2d22
(2a12b12γ − 1) ,
b23 =
(a13b12 + a12b13) γ
d22 + d33
, b33 = −
1
2d13
(2a13γb13 − 1) . (5.5)
Consider now, the quadratic function
V1 (x) = X
TB1X = b11 (x1 − γ)
2
+ b22x
2
2 + b33x
2
3+
2b12 (x1 − γ)x2 + 2b13 (x1 − γ)x3 + 2b23x2x3.
It is clear to see that
V1 (x) = b11 (x1 − γ)
2
+ 2b12 (x1 − γ)x2 + b22x
2
2 + 2b13x1x3+
b33x
2
3 + 2b23x2x3 =
b11
2
(
x1 − γ +
2b12
b11
x2
)2
+
[
b22
2
−
2b212
b11
]
x22+
b11
2
(
x1 − γ +
2b13
b11
x3
)2
+
[
b33
2
−
2b233
b11
]
x23+ (5.6)
b22
2
(
x2 +
2b23
b22
x3
)2
+
[
b33
2
−
2b223
b22
]
x23 ≥ 0,
i.e. V1 (x) is a positive defined Lyapunov function candidate in neighborhood
of E1 ⊂ ΩK when the assumption (3) hold. By [12, Corollary 8.2] we need
now to determine a domain Ω1 about the point E1, where V˙1 (x) is negatively
defined and a constant C such that ΩC is a subset of Ω1. By assuming xk ≥ 0,
k = 1, 2, 3, we will find the solution set of the following inequality
V˙1 (x) =
3∑
k=1
∂V1
∂xk
dxk
dt
= (5.7)
2 [b11 (x1 − γ) + b12x2 + b13x3]x1 [(1− x1)− a12x2 − a13x3 − g1 (υ)]+
2 [b12 (x1 − γ) + b22x2 + b23x3]x2 [r2 (1− x2)− a21x1 − g2 (υ)] +
2 [b23x2 + b13 (x1 − γ) + b33x3]x3
[
r3x1
x1 + k3
− a31x1 − d3 − g3 (υ)
]
< 0.
By assumption (1) b11, b22, b33 > 0, b12, b13 < 0, b23 > 0. So, by assumption
(2), some coefficients of terms x1x2, x1x2, x
3
3, x1x
2
2, x
2
1x2, x1x2x3 are negative.
Hence, the estimate (5.7) holds if
η11x
2
1 + η22x
2
2 ++η33x
2
3 + 2b11γ [a12x1x2 + a13x1x3] < 0, (5.8)
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α1x1 + α2x2 + α3x3 < 0,
where,
η11 = 2b11 [1 + γ − g1 (υ)] , η22 = 2b12γ + 2r2b22 − 2b22g2 (υ) ,
η33 = −2d3, α1 = 2b11γ [g1 (υ)− 1] , α2 = 2b12γ [g2 (υ)− r2] ,
α3 = 2b13 [g3 (υ) + d3] .
By assumption (4) and in view of (5.5) , ηii > 0 for i = 1, 2, 3. Moreover, by
applying (5.2) we get that (5.8) hold if
µ1 (x1 − γ)
2
+ η2x
2
2 + µ3x
2
3 < µ1γ
2, (5.9)
(α1 + 2µ1)x1 + α2x2 + α3x3 ≤ 0,
where
µ1 = η11 + b11γa12, µ2 = η22 + b11γa13.
Hence, V˙1 is negative defined on the domain Ω1 = Br (x¯) ∩ Ωγ , if
(x1 − γ)
2
+ x22 + x
2
3 < r
2, (5.10)
(α1 + 2µ1)x1 + α2x2 + α3x3 ≤ 0,
where
x¯ = (γ, 0, 0) , r =
(
µ0
µ1γ
2
) 1
2
, µ0 = max {µ1, η2, µ3 } ,
r ≤
√
K21 +K
2
2 +K
2
3 , Ωγ =
{
x ∈ R3+, (α1 + 2µ1)x1 + α2x2 + α3x3 ≤ 0
}
.
(5.11)
i.e., the system (1.11) is global asymptotically stabile at E1 (γ, 0, 0).
Remark 5.1. In view of (5.5), the assumption (3) can be realized as the
condition on the coefficients of the system (1.11) .
Let cii be the numbers defined by (3.4) . Now, we consider the equilibria
point E2 (0, δ, 0) and prove the following result
Theorem 5.2. Assume (1) c11 < 0, δ = 1−
g2(υ)
r2
> 0, c22 < 0 (2) g1 (υ) < 1;
(3)
g1 (υ) + g2 (υ) + r2 > r2 (δ − 1) , g1 (υ)− 1 > δ (a12 + 1) .
Then the system (1.11) is global asymptotically stabile at equilibria point
E1 (0, δ, 0) .
Proof. Let A2 be the linearized matrix with respect to equilibria point
E2 (0, δ, 0) , i.e.
A2 =

 c11 0 0−a21δ c22 0
0 0 c33

 .
Consider the Lyapunov equation
B2A2 +A
T
2 B2 = −I, (5.12)
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where
B2 =

 b11 b12 b13b21 b22 b23
b31 b32 b33

 .
The equation (5.12) is reduced to the linear system of algebraic equation in bij
and by solving this system we get
b13 = 0, b22 = −
1
2c22
, b12 = b21 = −
a21δ
2c22 (c11 + c22)
,
b11 = −
1
c11
[
a221δ
2
2c22 (c11 + c22)
+
1
2
]
, b23 = b32 = 0,
b33 = −
1
2d33
, b13 = b31 = 0, B2 =

 b11 b12 0b12 b22 0
0 0 b33

 . (5.q2)
Moreover,
P2 (λ) = (b33 − λ)
[
λ2 − (b11 + b22)λ−
(
b212 − b11b22
)]
= 0. (5.13)
In view of the assumption (1) and (2) it is clear to see that
b11 > 0, b22 > 0, b33 > 0, b12 < 0.
By assumption (3),
(b11 + b22)
2
+ 4
(
b212 − b11b22
)
= (b11 − b22)
2
+ 4b212 ≥ 0.
So, (5.13) has positive roots, i.e. the matrix B2 is positive defined for all x.
Hence, the quadratic function
V2 (x) = X
TP2X = b11x
2
1 + 2b12x1 (x2 − δ) + 2b22 (x2 − δ)
2
+ b33x
2
3 (5.v2)
is a positive defined Lyapunov function candidate in certain neighborhood of
E2 (0, δ, 0). We need to determine a domain Ω2 about the point E2, where
V˙2 (x) is negative defined and a constant C such that ΩC is a subset of Ω2. By
assuming x ∈ R3+ we will find the solution set of the following inequality,
V˙2 (x) =
3∑
k=1
∂V2
∂xk
dxk
dt
=
[2b11x1 + 2b12 (x2 − δ)] [(1− x1)− a12x2 − a13x3 − g1 (υ)]x1+
[2b22 (x2 − δ) + 2b12x1] [r2 (1− x2)− a21x1 − g2 (υ)]x2+
b33x
2
3
[
r3x1
x1 + k3
− a31x1 − d3 − g3 (υ)
]
< 0. (5.14)
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By assumptions, the coefficients of terms x31, x
3
2, x1x
2
2, x
2
1x2, x1x2x3 and some
coeffcients of x1x2, x1x3 are negative. So, by assumption (2) and by (6q2) for
x ∈ R3+ the inequality (6.14) holds if
[2b11 (1− g1 (υ))− 2δb12g1 (υ)]x
2
1 + 2δb22 [r2 + g2 (υ)]x
2
2−
b33 (d3 + g3 (υ))x
2
3 + [−2δb12a12 + 2δb22a21 − 2b12g1 (υ)]x1x2+
2δb12g1 (υ)x1 + [2b22g2 (υ) (δ − r2)]x2+
− [2b12r2 + 2b22a21]x1x
2
2 + {2b12 [g1 (υ)− a21]− 2b11a12}x
2
1x2 < 0.
By assumption (3)
− [2b12r2 + 2b22a21] < 0, {2b12 [g1 (υ)− a21]− 2b11a12} < 0.
Hence, in view of inequalities (6.2), the above inequality holds if
µ0
[
x21 + (x2 − δ)
2
+ x23
]
< µ0δ
2 − b12 (δa12 + g1 (υ)) + δb22a21,
2δb12g1 (υ)x1 + [2b22g2 (υ) (δ − r2) + 2µ0δ]x2 ≤ 0, (5.15)
where
µ1 = [2b11 (1− g1 (υ))− 2δb12g1 (υ)] , µ2 = 2δb22 [r2 + g2 (υ)] ,
µ3 = b33 (d3 + g3 (υ)) , µ0 = max {µ1, µ2, µ3} .
From (5.q2) it is easy to see that µk > 0. Hence, V˙2 is negative defined on
the domain Ω2 = Br (x¯) ∩ Ωδ, where
x¯ = (0, δ, 0) , r =
(
η
µ0
) 1
2
, r ≤
√
K21 +K
2
2 +K
2
3 ,
η = µ0δ
2 − b12 (δa12 + g1 (υ)) + δb22a21 + µ2δ
2,
Ωδ =
{
x ∈ R3+, 2δb12g1 (υ)x1 + [2b22g2 (υ) (δ − r2) + 2µ0δ]x2 ≤ 0
}
. (5.q3)
i.e., the system (1.11) is global asymptotically stabile at E1 (0, δ, 0).
6. Basins of multiphase attraction sets
In this section we will derive momains of multipoint attraction sets, E0 (0, 0, 0) ,
E1 (γ, 0, 0), E2 (0, δ, 0) , where γ, δ were defined by (3.2) .
We show in this section the following results
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Theorem 6.0. Assume that all conditions of Theorem 5.0 are satisfied.
Then the basin of multiphase attraction set of the point E0 (0, 0, 0) belongs to
the set ΩC ⊂ ΩK , where the positive constant C is defined in bellow.
Proof. Let us now find the set ΩC ⊂ Br (x¯) , where
C < min
|x|=r
V0 (x) = λmin (P0) r
2,
here P0 was defined by (6.0), λmin (P0) denotes a minimum eignevalue of P0,
i.e.
λmin (P1) = min {b11, b22, b33}
and
r ≤
√
K21 +K
2
2 +K
2
3 .
Moreover, for some C > 0 the inclusion ΩC ⊂ ΩK means the existence of
C > 0 so that x ∈ ΩC implies x ∈ ΩK , i.e.
0 ≤ xi ≤ Ki, Ki > λmin (P1) .
Theorem 6.1. Assume that all conditions of Theorem 6.1 are satisfied.
Then the basin of multiphase attraction set of the point E1 (γ, 0, 0) belongs to
the set ΩC ⊂ ΩK ∩ Ωγ ∩ Br (x¯) , where Ωγ was defined by (5.q1), the positive
constant C and r were defined in bellow.
Proof. Let us now find the set ΩC ⊂ Br (x¯) , where
C < min
|x−x¯|=r
V1 (x) = λmin (P1)
η
µ0
, x¯ = (γ, 0, 0) , P1 (λ) = |B1 − λ| ,
here B1 is a matrix defined by (5.5), λmin (P1) denotes a minimum eignevalue
of P1, η, µ0 were defined by (5.10) and (5.11) . Moreover, for some C > 0 the
inclusion ΩC ⊂ Ωγ means the existence of C > 0 so that x ∈ ΩC implies x ∈ Ωγ ,
i.e.
0 ≤ xi ≤ Ki, x1 ≤ −
1
α1 + 2µ1
[α2x2 + α3x] ,
αı, µı were defined by (5.q2) .
So,
x ∈ Br (x¯) =
{
x ∈ R3, |x− x¯| < r0
}
,
where
r0 = min
{(
µ0
µ1γ
2
) 1
2
,
[
2γ2 +
(
2κ22 + 1
)
K22 + κ
2
2K
2
3
] 1
2
}
,
κ2 =
∣∣∣∣ α2α1 + 2µ1
∣∣∣∣ , κ3 =
∣∣∣∣ α3α1 + 2µ1
∣∣∣∣ .
Then we obtain that
C < min
|x−x¯|=r¯
V1 (x) = λmin (P1) r¯
2,
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i.e.
C < λmin (P1) r¯
2, r = min {r0, r¯} .
Then we obtain that
C < min
|x−x¯|=r¯
V1 (x) = λmin (P1) r¯
2,
i.e.
C < λmin (P1) r¯
2, r = min {r0, r¯} .
Now, we consider the equilibria point E2 (0, δ, 0) and prove the following
result
Theorem 6.2. Assume all conditions of Theorem 5.2 are satisfied. Then
the basin of multiphase attraction set of E2 (0, δ, 0) belongs to the set ΩC ⊂
ΩK ∩ Ωδ ∩Br (x¯) , where Ωδ was defined by (5.q3) and
ΩC =
{
x ∈ R3: V2 (x) ≤ C
}
, x¯ = (0, δ, 0) ,
here V2 (x) was defined by (6.v2), the constants C and r are defined in bellow.
Proof. We will find C > 0 such that ΩC ⊂ ΩK ∩Br (x¯) ∩Ωδ. It is clear to
see that ΩC ⊂ Br (x¯) , when
C < min
|x−x¯|=r
V2 (x) = λmin (P2) r
2, x¯ = (0, δ, 0) ,
here λmin (P2) denotes a minimum eigenvalue of P2, i.e.
λmin (P2) = min

 12d3 ,
(
b22 +
1
2r2
)
±
√
b211 + b
2
12 +
1
4r2
2
− b11
r2
2

 .
Moreover, for some C > 0 the inclusion ΩC ⊂ Ωδ means the existence of
C > 0 so that x ∈ ΩC implies x ∈ Ωδ, i.e.
x ∈ ΩK , x2 ≤ βx1, β = −
2δb12g1 (υ)
[2b22g2 (υ) (δ − r2) + 2µ0δ]
. (6.1)
So, x ∈ Br¯ (x¯), where µi were defined by (5.15) and
r¯ =
[
K21 + β
2 (K1 − δ)
2 +K23
] 1
2
.
Then we obtain that
C < min
|x|=r0
V2 (x) = λmin (P2) r
2
0 ,
i.e.
C < λmin (P2) r
2 for r = min {r0, r¯} .
Remark 6.1. It is clear to see that if a21 ≥
a12−1
r2
, then the assumption (3)
is satisfied. Moreover, if a12 +
1
2 (1 + a13) > r2, then the assumption (4) holds.
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Remark 6.2. The assumptions (3) and µi > 0 can be realized in terms of
coefficients of (1.3) by using (5.20) .
Conclusion. 1. Multipoint Initial Condition (MIC): The condition deter-
mining initial state of complex system consisted of tumor cells, Immune cells
– natural killer and host cells densities at the beginning of observation; this
condition is can be enriched with addition to the system drug concentration.
2. MIC is operated not only by changing the concentrations of the complex
system parameters, but also taking into account the impact of the drug effects
on the parameters, in order to direct the system to possible equilibrium points.
3. The possible equilibrium points can be selected and reached by the help by
changing the situation in behalf of a new, more effective equilibrium point, one
of multimodal attraction points, which multimodal attraction basin is consisted
of. This operation drifts the complex system into situation, where Tumor Cells
are trying to reach at least “Dormant State” that creates new chance to get
more important condition as healthy attraction point, which can be estimated
as globally stable condition.
a) All these operations are traced beginning local lipschitz condition (Theo-
rem 2.1) application to IVP, being developed to global lipschitz condition (The-
orem 2.2). The conditions make it possible to figure out positive multiphase
attractor and multiphase basin;
b) By the help of Remarks (3.1) and (3.2.) the equilibrium points are de-
scribed. These points relate to situation impeding tumor cell growth;
c) Theorem (4.1) makes it possible to reach asymptotically stable point
(point, the function in the included conditions continuously approaches the
point) depending on relationships between kill rate of drug and rate of tumor
cell proliferation. Rate of Immune cell killing by tumor cells is also consid-
ered for reaching the point. For reaching the target, condition of positivity in
relationships between combinations of different rates (cii) were included;
d) By the help of Theorems (4.1. – 4.7.), the main parametric conditions
are proved and determined for strong multipoint attractor, corresponding to
suppression of tumor growth, the possible healthy stable point in Multimodal
attraction basin;
e) The important condition as a strong impact on tumor growth is reached
by proving theorems (5.0. – 5.2) as global stability of equilibria points and
multiphase attraction sets;
(f) Theorems (6.0. – 6.2.) describe the condition determining Multiphase
Attraction Set Basin, within which tumor cells are successfully suppressed;
Taking into account different and effective features of mathematical mod-
elling and its possibilities to figure out a problem in dynamics on the basis of
its logic properties, it was surely pointed out the characteristics of a mathemat-
ical model to use in description of needed processes of a given dynamic system
with identified problems. In this paper, a three dimensional model was devoted
to mathematical description and regulation possibilities of uncontrolled tumor
processes by organism as a complex system. The dynamics of interactions of
the dimensions corresponded to tumor cells, immune cells and healthy – “host”
– cells were given as forces of vectors, with addition another one vector as a
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drug, negatively or positively converging to the basins of attractions, depending
on their importances for the complex system consisted of the four factors. In
order to make the model subjected to control, there was included multiphase
IVP, describing the system’s important parameters to operate with it in the
farther processes of stages of development. The model was undergone different
changes to determine its limits of survival: it was determined the conditions of
boundedness the system can be restricted, invariance in non- negativity, which
means the model keeps its properties of reactions to changing in proper way,
being subjected to different analysis, and the circumstances the system can be
forced to be dissipated in. The system was exposed to changing pressures to
estimate its convenience to biologically important properties as points of equi-
libria and local stability conditions. The next step in exploring of the model
were very complex and logistic approaches to its properties for verification of
the conditions, providing the global equilibria points and multimodal attraction
sets, having biologically strong value in regulation of the processes towards the
positive effects of feasible medical external implementation at the convenient
stages, determined by multimodal attraction basins.
It is reasonable to observe of pationts, to get analysis (e.g. the status of
blood cells shown above) at different times that determines the states patient
at these times (maltipoint times) and its correlation. Moreover, to define the
system to be in stable, healthy state if it is in the basin of multimodal attraction
healthy point. Furthermore, it is reasonable that a mathematical model of such
a system should include at least two stable multimodal attracting basin, one of
which is considered “healthy” and another which is “diseased”. For if this were
not the case, we would not observe both types of behavior. A system with only
an multipoint attracting healthy state would never need to be treated, since it
would naturally move back to this state despite any exogenous shock. On the
other hand, a system with no multimodal attracting healthy state would never
stay cured, and no remission from disease would ever be observed.
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